Kurve Therapeutics Webinar

Watch Kurve Therapeutics CEO Marc Giroux and Chief Science Officer Glenn Cornett, MD, Ph.D. in their latest webinar.

Alzheimer's Treatments: A New and Efficient Approach

Marc Giroux

Chairman & CEO

Marc Giroux is a serial entrepreneur with 25 years of experience in C-level business development, the founder of 5 companies so far, and the innovative mind behind Kurve’s breakthrough technology. As the Chairman and CEO of Kurve, Marc builds upon his prior knowledge and experience to establish Kurve as a leader in innovation and technology within the pharmaceutical industry.

Glenn Cornett, MD, PH.D.

Chief Science Officer

Dr. Glenn Cornett is a biotech entrepreneur and advisor who has spent the last decade of his impressive career developing drugs for psychiatric and neurological indications. He holds an M.D. with Distinction in Research from the university of Michigan and a Ph.D. in neuroscience such as Eli Lily, McKinsey, Razorfish, and the Los Alamos National Laboratory.

About the Webinar:

Watch the webinar to hear this powerhouse team discuss Kurve’s new approach to Alzheimer’s disease treatments and how they plan to address a dire global need for the 55 million Alzheimer’s patients who need their help.

This webinar includes:

  • How Kurve’s patented technology holds the key to a new, efficient treatment option for Alzheimer’s disease
  • The current landscape in available. Alzheimer’s treatments
  • Kurve’s upcoming Regulation A+ Offering

Sign up to be the first to know when we go live

Register for Webinar